Central pontine myelinolysis during treatment of hyperglycemic hyperosmolar syndrome: a case report
Tóm tắt
Central pontine myelinolysis (CPM) is a non-inflammatory demyelinating lesion of the pons. CPM and extrapontine demyelination (EPM) are together termed osmotic demyelination syndrome (ODS), a known and serious complication of acute correction of hyponatremia. Conversely, hyperglycemic hyperosmolarity syndrome (HHS) develops in patients with type 2 diabetes who still have some insulin secretory ability due to infection, non-compliance with treatment, drugs, and coexisting diseases, and is often accompanied by ketosis. HHS represents a life-threatening endocrine emergency (mortality rate, 10–50%) associated with marked hyperglycemia and severe dehydration. HHS may develop ODS, and some cases have been associated with hypernatremia.
The patient was an 87-year-old woman with hyperglycemia, dehydration, malnutrition, and potential thrombus formation during long-term bed rest. HHS was suspected to have developed due to progression of hyperglycemia and dehydration caused by pneumonia. Furthermore, ketoacidosis developed from ketosis and prerenal renal failure associated with circulating hypovolemia shock, which was also associated with disseminated intravascular coagulation. Treatment was started with continuous intravenous injection of fast-acting insulin and low-sodium replacement fluid. In addition, ceftriaxone sodium hydrate, heparin sodium, thrombomodulin α, human serum albumin, and dopamine hydrochloride were administered. Blood glucose, serum sodium, serum osmolality, and general condition (including vital, infection/inflammatory findings, and disseminated intravascular coagulation) improved promptly, but improvements in disturbance of consciousness were poor. Diffusion-weighted imaging of the brain 72 h after starting treatment showed no obvious abnormalities, but high-intensity signals in the midline of the pons became apparent 30 days later, leading to definitive diagnosis of CPM.
Fluctuation of osmotic pressure by treatment from hyperosmolarity due to hyperglycemia and hypernatremia in the presence of risk factors such as malnutrition, severe illness, and metabolic disorders may be a cause of CPM onset. When treating HHS with risk factors, the possibility of progression to ODS needs to be kept in mind.
Từ khóa
Tài liệu tham khảo
Sterns RH, Riggs JE, Schochet SS Jr. Osmotic demyelination syndrome following correction of hyponatremia. N Engl J Med. 1986;314:1535–42.
Kengne FG, Nicaise C, Soupart A, Boom A, Schiettecatte J, Pochet R, Brion JP, Decaux G. Astrocytes are an early target in osmotic demyelination syndrome. J Am Soc Nephrol. 2011;22:1834–45.
Murase T, Sugimura Y, Takefuji S, Oiso Y, Murata Y. Mechanisms and therapy of osmotic demyelination. Am J Med. 2006;119:S69–73.
Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry. 1959;81:154–72.
Ayus JC, Krothapalli RK, Arieff AI. Treatment of symptomatic hyponatremia and its relation to brain damage. A prospective study. N Engl J Med. 1987;317:1190–5.
McKee AC, Winkelman MD, Banker BQ. Central pontine myelinolysis in severely burned patients: relationship to serum hyperosmolality. Neurology. 1988;38:1211–7.
Shah MK, Mandayam S, Adrogué HJ. Osmotic demyelination unrelated to hyponatremia. Am J Kidney Dis. 2018;71:436–40.
Stoner GD. Hyperosmolar hyperglycemic state. Am Fam Phys. 2017;96:729–36.
Landers JW, Chason JL, Samuel VN. Central pontine myelinolysis: a pathogenic hypothesis. Neurology. 1965;15:968–71.
Kusuyama Y, Tanaka S, Sakatsuji K, Nishihara T, Saito K, Ikeda K, Inui J, Iwahashi Y. Central pontine myelinolysis: an immunofluorescent study. Acta Pathol Jpn. 1982;32:725–32.
McComb RD, Pfeiffer RF, Casey JH, Wolcott G, Till DJ. Lateral pontine and extrapontine myelinolysis associated with hypernatremia and hyperglycemia. Clin Neuropathol. 1989;8:284–8.
O’Malley G, Moran C, Draman MS, King T, Smith T, Thompson CJ, Agha A. Central pontine myelinolysis complicating treatment of the hyperglycaemic hyperosmolar state. Ann Clin Biochem. 2008;45:440–3.
Burns JD, Kosa SC, Wijdicks EF. Central pontine myelinolysis in a patient with hyperosmolar hyperglycemia and consistently normal serum sodium. Neurocrit Car. 2009;11:251–4.
Mao S, Liu Z, Ding M. Central pontine myelinolysis in a patient with epilepsia partialis continua and hyperglycaemic hyperosmolar state. Ann Clin Biochem. 2011;48:79–82.
Hegazi MO, Mashankar A. Central pontine myelinolysis in the hyperosmolar hyperglycaemic state. Med Princ Pract. 2013;22:96–9.
Guerrero WR, Dababneh H, Nadeau SE. Hemiparesis, encephalopathy, and extrapontine osmotic myelinolysis in the setting of hyperosmolar hyperglycemia. J Clin Neurosci. 2013;20:894–6.
Rodríguez-Velver KV, Soto-Garcia AJ, Zapata-Rivera MA, Montes-Villarreal J, Villarreal-Pérez JZ, Rodríguez-Gutiérrez R. Osmotic demyelination syndrome as the initial manifestation of a hyperosmolar hyperglycemic state. Case Rep Neurol Med. 2014;2014:652523. https://doi.org/10.1155/2014/652523.
Saini M, Mamauag MJ, Singh R. Central pontine myelinolysis: a rare presentation secondary to hyperglycaemia. Singapore Med J. 2015;56:e71–3.
Donnelly H, Connor S, Quirk J. Central pontine myelinolysis secondary to hyperglycaemia. Pract Neurol. 2016;16:493–5.
Talluri S, Charumathi R, Khan M, Kissell K. Atypical presentation of central pontine myelinolysis in hyperglycemia. Endocrinol Diabetes Metab Case Rep. 2017;17:0064. https://doi.org/10.1530/EDM-17-0064.
Hirosawa T, Shimizu T. Osmotic demyelination syndrome due to hyperosmolar hyperglycemia. Cleve Clin J Med. 2018;85:511–3.
Blas-Macedo J, Blas-Soto V. Hypernatremia in hyperosmolar hyperglycemic syndrome. Rev Med Inst Mex Seguro Soc. 2011;49:335–7.
Graff-Radford J, Fugate JE, Kaufmann TJ, Mandrekar JN, Rabinstein AA. Clinical and radiologic correlations of central pontine myelinolysis syndrome. Mayo Clin Proc. 2011;86:1063–7.
Förster A, Nölte I, Wenz H, Al-Zghloul M, Kerl HU, Brockmann MA, Brockmann C, Groden C. Value of diffusion-weighted imaging in central pontine and extrapontine myelinolysis. Neuroradiology. 2013;55:49–56.
Ruzek KA, Campeau NG, Miller GM. Early diagnosis of central pontine myelinolysis with diffusion-weighted imaging. Am J Neuroradiol. 2004;25:210–3.
Chua GC, Sitoh YY, Lim CC, Chua HC, Ng PY. MRI findings in osmotic myelinolysis. Clin Radiol. 2002;57:800–6.
Go M, Amino A, Shindo K, Tsunoda S, Shiozawa Z. A case of central pontine myelinolysis and extrapontine myelinolysis during rapid correction of hypernatremia. Rinsho Shinkeigaku. 1994;34:1130–5.
Takefuji S, Murase T, Sugimura Y, Takagishi Y, Hayasaka S, Oiso Y, Murata Y. Role of microglia in the pathogenesis of osmotic-induced demyelination. Exp Neurol. 2007;204:88–94.